utilized a microfluidic chip, which mimics the breast cancer microenvironment and breast metastatic phenotypes in vitro, and found that IL-6-treated breast cancer cells successfully invaded into blood and lymph vessels mimicking breast cancer lymphatic metastasis in vitro (115). This evidence concerns the gene IL6 and breast cancer.